ATHIRA ATH-1017-AD-0202
Back to Drug Development Trials
![]()
Drug Development Trials
About the ATHIRA ATH-1017-AD-0202 trial
A Randomized, Placebo-Controlled, Translational Study of ATH-1017 in Subjects With Mild to Moderate Alzheimer’s Disease.
